Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of health care company Centene
So what: Third-quarter revenue came in at $1.3 billion and earnings per share tallied up to $0.55. Analysts were expecting $1.3 billion in revenue and $0.54 in earnings per share. The portion of premiums spent on medical costs ticked down to 83%.
Now what: The company now expects full-year earnings per share in the range of $2.09-$2.13, up from the previously guided range of $2.03-$2.13. Full-year revenue is expected in the ballpark of $5.1 billion-$5.2 billion, up from $5 billion-$5.2 billion. As a follow-up to the results, Wells Fargo came out with an upgrade intraday, moving the stock's rating from market perform to outperform while increasing its valuation range from $30-$32 up to $39-$42.
Interested in more info on Centene? Add it to your watchlist by clicking here.